Dr. Rossi Unveils the Future of CLL Care: Advanced Treatments, Personalized Approaches, and Emerging Clinical Trials.
Understanding Chronic Lymphocytic Leukemia (CLL) with Dr. Jean-François Rossi
Massive Bio invites you to an informative webinar on Chronic Lymphocytic Leukemia (CLL), featuring Dr. Jean-François Rossi, Professor of Hematology at the University of Montpellier and a leading specialist in B-cell malignancies.
Dr. Rossi will discuss the latest advancements in CLL diagnosis and treatment, including targeted therapies, immunotherapy, and personalized approaches. He will also explore the importance of monitoring, risk assessment, and emerging clinical trials in shaping the future of CLL care.
What to Expect:
- Understanding CLL: How it differs from other leukemias
- Risk Factors & Epidemiology: Who is at risk and why
- Diagnostic Process: Key tests, staging, and prognostic markers
- Standard Treatments: From observation to targeted therapies
- Breakthrough Therapies: BTK inhibitors, anti-CD20, and evolving treatment strategies
- Managing Side Effects & Infections: Improving patient quality of life
- Clinical Trials & Emerging Research: Accessing cutting-edge therapies
- Personalized Treatment Plans: How healthcare teams tailor treatments for better outcomes
This session is a valuable opportunity for patients, caregivers, and healthcare professionals to learn from an expert and explore the evolving landscape of CLL treatment.
Meet the Speakers

Jean Francois Rossi, MD, PhD
Hematologist

Fiona Evans
Director, Patient Relations
Discover Your Options, Today
Interested in learning more about how clinical trials could be part of your cancer care strategy?
Let’s explore opportunities for your best options, together.
Discover your personalized cancer clinical trials options
Discover your personalized cancer clinical trials options
Understanding Chronic Lymphocytic Leukemia (CLL) with Dr. Jean-François Rossi
Join Our Webinar: Understanding Chronic Lymphocytic Leukemia (CLL) with Dr. Jean-François Rossi
Massive Bio invites you to an informative webinar on Chronic Lymphocytic Leukemia (CLL), featuring Dr. Jean-François Rossi, Professor of Hematology at the University of Montpellier and a leading specialist in B-cell malignancies.
Dr. Rossi will discuss the latest advancements in CLL diagnosis and treatment, including targeted therapies, immunotherapy, and personalized approaches. He will also explore the importance of monitoring, risk assessment, and emerging clinical trials in shaping the future of CLL care.
What to Expect:
- Understanding CLL: How it differs from other leukemias
- Risk Factors & Epidemiology: Who is at risk and why
- Diagnostic Process: Key tests, staging, and prognostic markers
- Standard Treatments: From observation to targeted therapies
- Breakthrough Therapies: BTK inhibitors, anti-CD20, and evolving treatment strategies
- Managing Side Effects & Infections: Improving patient quality of life
- Clinical Trials & Emerging Research: Accessing cutting-edge therapies
- Personalized Treatment Plans: How healthcare teams tailor treatments for better outcomes
This session is a valuable opportunity for patients, caregivers, and healthcare professionals to learn from an expert and explore the evolving landscape of CLL treatment.
Meet the Speakers

Jean Francois Rossi, MD, PhD
Hematologist

Fiona Evans
Director, Patient Relations